Avant Technologies and SGAustria Form Joint Venture to Develop Stem Cell-Based Diabetes Therapy Read more
UCB Secures FDA Approval for KYGEVVI, the First-Ever Treatment for Ultra-Rare TK2 Deficiency Read more
IntoCell and Xcellon Biologics Partner to Advance Next-Generation ADC Development and Manufacturing Read more
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ First-in-Class Gastric Cancer Drug Read more